nav open
¸Þ´º
nav open
PRODUCTS
Á¦Ç°/ºê·£µå
SUPPORT
°ßÀû/ÁÖ¹®
COMMUNITY
°øÁö»çÇ×
ÇÁ·Î¸ð¼Ç
ABOUT
°æ¿µÀ̳ä
¿¬¶ôó
COMMUNITY
ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.
Ä¿¹Â´ÏƼ
Community
°øÁö»çÇ×
ÇÁ·Î¸ð¼Ç
Ȩ
Ä¿¹Â´ÏƼ
ÇÁ·Î¸ð¼Ç
ÇÁ·Î¸ð¼Ç
ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
¹øÈ£
Á¦¸ñ
ÀÛ¼ºÀÚ
ÀÛ¼ºÀÏÀÚ
Á¶È¸¼ö
481
[Abbaltis] Autoimmune material - July 21
abbabio
2022-07-21
46
480
[Abbaltis] Infectious disease material offer - July 21
abbabio
2022-07-21
40
479
[Cusabio] CLDN6, the "New Favorite" in Targeted Cancer Therapy after CLDN 18.2
abbabio
2022-07-21
64
478
[Abbaltis] NEW Product Line - Luteinising Hormone - July 20
abbabio
2022-07-20
43
477
[Abbaltis] Infectious offer - July 20
abbabio
2022-07-20
51
476
[Abbaltis] Allergy material available - July 20
abbabio
2022-07-20
86
475
[Cusabio] To explore key genes in "Cuprotosis", improving future treatment in Wi..
abbabio
2022-07-14
78
474
[Kerafast] From the Freezer: July 2022 Kerafast E-Newsletter
abbabio
2022-07-14
39
473
[Abbaltis] Allergy material available
abbabio
2022-07-11
41
472
[Cusabio] 193 Articles Updated Using ELISA, Protein, Antibody! Impact Factor Tot..
abbabio
2022-07-11
50
1
2
3
4
5
6
7
8
9
10
Á¦¸ñ
ÀÛ¼ºÀÚ
³»¿ë